Download the whitepaper to learn how pharmaceutical and life sciences leaders are using AI-driven decision intelligence to reduce excess inventory, cut logistics costs, improve service levels, and build more agile, resilient operations that deliver better outcomes for both the business and patients.
Highlighting our work with global pharmaceutical companies who have adopted decision intelligence to transform their supply chains, this whitepaper details how these companies are leveraging AI-driven capabilities to reduce excess and safety stock inventory, cut expedited logistics costs, boost service levels, and minimize planner workload.
- Reduce Excess Inventory by 20-30% with intelligent inventory rebalancing
- Boost Service Levels by 8-10% through supplier collaboration
- Cut Expedited Logistics Costs by up to 75% with demand sensing
- Cut Safety Stock Inventory by 15-30% with dynamic safety stock adjustments
- Reduce Planner Workload by 7-10% through constrained material supply
Read the paper to learn how pharma and life sciences companies are leveraging the Aera Decision Cloud to make smarter, faster, and more proactive decisions, driving resilience, operational efficiency, and sustainable growth across their supply chain operations.
“Aera is helping us solve huge pain points for our customers around the globe. They can now more efficiently run their practices and schedule their appointments, knowing they will have the right products in stock.”
— Sara Kelly, Vice President, Digital Health
Alcon
Offered Free by: Aera Technology
See All Resources from: Aera Technology
